[177Lu]Lu-DOTA-IBA plus EGFR-TKIs versus [177Lu]Lu-DOTA-IBA monotherapy for EGFR-mutated advanced non-small-cell lung cancer (NSCLC) with bone metastases: a prospective study
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Lung Cancer Treatments and Mutations
Radiopharmaceutical Chemistry and Applications
Lung Cancer Diagnosis and Treatment
Publication details
- Journal / source
- European Journal of Nuclear Medicine and Molecular Imaging
- Volume
- 53
- Issue
- 9
- Pages
- 5198–5207
- Publication date
- 31 March 2026
- Language
- EN